Capital Performance Advisors LLP Akoya Biosciences, Inc. Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Capital Performance Advisors LLP holds 142 shares of AKYA stock, worth $435. This represents 0.0% of its overall portfolio holdings.
Number of Shares
142Holding current value
$435% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AKYA
# of Institutions
57Shares Held
12MCall Options Held
24.1KPut Options Held
0-
Blue Water Life Science Advisors, LP Larkspur, CA4.7MShares$14.4 Million11.23% of portfolio
-
Black Rock Inc. New York, NY1.5MShares$4.61 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.48MShares$4.56 Million0.0% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX790KShares$2.43 Million3.97% of portfolio
-
Geode Capital Management, LLC Boston, MA562KShares$1.72 Million0.0% of portfolio
About Akoya Biosciences, Inc.
- Ticker AKYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,892,300
- Market Cap $116M
- Description
- Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...